Key Takeaways
- ORCL shares experienced a brutal nine-session decline, shedding 24% in its longest losing streak since late 2021.
- The stock hovers around $140, marking a 27% decline over half a year and approaching its 52-week bottom.
- Wall Street remains optimistic with 84% of analysts rating ORCL as a Buy, averaging a $254.84 price target.
- Market anxiety stems from Oracle’s aggressive capital spending plans and expanding debt obligations.
- Piper Sandler identifies approximately $2.2 billion in potential OCI revenue for FY2027 not reflected in current projections.
Oracle (ORCL) shares are showing signs of life Monday morning, climbing roughly 3.5% in pre-market trading following a punishing nine-day slide. That prolonged selloff erased 24% of the stock’s value — marking the company’s worst stretch since late December 2021.
Currently, ORCL is hovering near $140.27, dangerously close to its 52-week floor and reflecting a 27% decline across the past six months. Even more striking, the stock now trades 57% beneath its all-time closing peak registered on September 10, 2025.
The downturn becomes particularly notable given the context. While the wider software industry has been staging a comeback — with the iShares Expanded Tech-Software Sector ETF logging five straight gains through last Thursday and climbing over 10% during that period — Oracle charted an entirely different course.
Since hitting a 2026 peak of $248.15 on June 1, ORCL has declined on 18 of the subsequent 22 trading sessions. This isn’t mere volatility; it represents a deliberate market pullback.
Market Concerns Driving the Decline
The primary issue isn’t Oracle’s growth trajectory. Rather, investors are focused on expenditures. Market participants are expressing unease regarding Oracle’s substantial capital outlay commitments and its mounting debt position. The enterprise is aggressively expanding its AI infrastructure capabilities, which demands significant financial resources.
Piper Sandler maintained its Overweight stance with a $225 target while acknowledging these precise investor anxieties. The firm highlighted apprehensions surrounding capital requirements for AI infrastructure development, customer concentration risks, margin pressures, and uncertainty about how AI investments translate into actual revenue generation.
Mizuho analyst Siti Panigrahi, among the street’s most optimistic voices with a $320 target, observed that Oracle will likely require external financing to support its capex ambitions. He explicitly identified “financing challenges” as a material risk factor — though this didn’t prevent him from naming ORCL among Mizuho’s preferred selections.
The Bullish Case Persists
Despite the dramatic selloff, Wall Street’s confidence hasn’t wavered significantly. A full 84% of analysts tracking ORCL maintain Buy ratings, according to FactSet data. This level of conviction has only been exceeded once in the past two decades — briefly during May 2011.
The consensus price target stands at $254.84 — suggesting approximately 82% upside potential from last Thursday’s closing price.
KeyBanc elevated its projections last month, expressing increased confidence that operating expense expansion will remain disciplined. The firm retained its Overweight rating with a $300 target, identifying cost management as the primary driver of future gains.
Evercore ISI sustained an Outperform rating with a $245 target, emphasizing Oracle’s AI-related backlog and highlighting that current remaining performance obligations reached $77 billion.
Piper Sandler’s research introduces an additional perspective: the firm estimates roughly 2,400 megawatts of OCI capacity could become operational during fiscal 2027, potentially generating approximately $2.2 billion in revenue not currently incorporated into consensus forecasts.
Freedom Broker reduced its target from $230 to $210 while maintaining a Buy recommendation, characterizing Oracle’s strategic shift toward AI compute infrastructure as fundamentally positive for long-term prospects.
Oracle’s PEG ratio presently registers at 0.69, which Piper Sandler interprets as indicating the stock appears undervalued when measured against its growth profile.
Trailing twelve-month revenue growth reached 17%, and Piper Sandler suggested the company’s new CFO might adopt more cautious guidance practices — potentially establishing a more achievable baseline that could facilitate stock recovery.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
